Literature DB >> 18812137

Anesthetic keratopathy after photorefractive keratectomy.

Jimmy K Lee1, Walter J Stark.   

Abstract

We report a case of anesthetic keratopathy after photorefractive keratectomy (PRK) and physician-prescribed topical anesthetic agents. After PRK for hyperopic correction, the patient was sent home with a bandage contact lens and instructions to use anesthetic eyedrops and take oral pain medications after surgery. During the first postoperative week, the eyes did not reepithelialize and bilateral perilimbal infiltrates developed. Cultures were negative and failed to clear with fortified antibiotic agents. On careful questioning, the patient admitted to instilling diluted tetracaine (0.05%) as needed in both eyes. She was instructed to stop the anesthetic agent labeled as "comfort drops" and the fortified antibiotics and start topical steroids. Soon after, the eyes reepithelialized and the infiltrates cleared. This case demonstrates the potential for anesthetic keratopathy in PRK patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18812137     DOI: 10.1016/j.jcrs.2008.04.051

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  3 in total

1.  Keratopathy due to ophthalmic drug abuse with corneal melting and perforation presenting as Mooren-like ulcer: A case report.

Authors:  Hui Wu; Yuan Hu; Xiao-Ru Shi; Feihong Xu; Chun-Ying Jiang; Rong Huang; Hui Jia
Journal:  Exp Ther Med       Date:  2016-04-27       Impact factor: 2.447

2.  Application of cold patch in relieving pain after transepithelial photorefractive keratectomy.

Authors:  Yuan Zeng; Yi Li; Jian-Hua Gao
Journal:  Pain Res Manag       Date:  2015-05-20       Impact factor: 3.037

3.  Anesthetic keratopathy presenting as bilateral Mooren-like ulcers.

Authors:  Hamid Khakshoor; Majid Moshirfar; Rachel G Simpson; Hamid Gharaee; Amir H Vejdani; Steven M Christiansen; Jason N Edmonds; Nicholas L Behunin
Journal:  Clin Ophthalmol       Date:  2012-10-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.